10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 272 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,581,034 | -37.9% | 1,347,419 | -16.0% | 0.16% | -39.1% |
| Q2 2023 | $89,520,901 | +199.2% | 1,603,168 | +198.9% | 0.27% | +186.0% |
| Q1 2023 | $29,921,906 | +17.2% | 536,331 | +212.8% | 0.09% | -8.8% |
| Q4 2021 | $25,541,000 | +491.4% | 171,462 | +618.6% | 0.10% | +410.0% |
| Q1 2021 | $4,319,000 | -85.5% | 23,860 | -88.6% | 0.02% | -86.2% |
| Q4 2020 | $29,699,000 | +145.4% | 209,738 | +116.1% | 0.14% | +133.9% |
| Q3 2020 | $12,104,000 | +229.9% | 97,077 | +136.3% | 0.06% | +158.3% |
| Q2 2020 | $3,669,000 | -76.9% | 41,085 | -83.9% | 0.02% | -81.4% |
| Q1 2020 | $15,894,000 | +79370.0% | 255,045 | +63661.2% | 0.13% | – |
| Q3 2019 | $20,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |